Regional Blood Center of Ribeirão Preto
Job Location
Rua Tenente Catão Roxo, 2501
Ribeirão Preto - São Paulo
Job Description

A postdoctoral position is available in the field of Stem Cell Biology and/or Leukemogenesis at the Center for Cell Therapy (CTC). CTC is located at the Regional Blood Center of the Ribeirão Preto Medical School (University of São Paulo – USP). CTC is a part of the Program of Research, Innovation and Dissemination supported by FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo).

The research at CTC focuses on stem biology and translational medicine with a multidisciplinary and collaborative efforts to: i) understand stem cell biology, highlighting pluripotent stem cells (embryonic and induced pluripotent stem cell) and somatic stem cells; and ii) to develop protocols for pre-clinical and clinical studies.

  • The candidate should have doctoral degree (PHD);

  • Previous experience in stem cell and/or leukemogenesis research, and knowledge of cell and molecular biology techniques (basic and advanced) are highly valued.

  • Good written and oral English communication skills are essential.

How to Apply

Applications must be sent to the e-mail: February, 29th 2016 at 18 pm (BRT). Additional information is found at: The successful candidate will be awarded with a FAPESP postdoctoral fellowship (

Interested applicants should submit a letter of motivation (1 page max), complete CV (2 pages max), and two recommendation letters with respective contact information of the reference until February, 29th 2016 to [email protected]

About Our Organization

The Center for Cell-based Therapy (CTC) is made up of a group of researchers of USP and of the Regional Blood Center of Ribeirão Preto who are interested in understanding the biology of stem cells, as well as in developing new technology for their use in the treatment of diseases. The group of researchers engages physicians, biologists, biomedical professionals, pharmacists and veterinarians, among others, that work together since 2000.

The researchers at CTC were responsible for the generation of the first embryonic stem cell line in Brazil and produced one of the first bovine and ovine clones in the country.

In the laboratory, CTC researchers have interest in signaling pathways of mammalian and human embryonic stem cells, in animal and human adult cells reprogramming to the embryonic state of pluripotency (iPS cells) and in the functioning of adult stem cells, such as hematopoietic, mesenchymal and cancer stem cells.

From stem cells derived from health people, CTC scientists investigate ways of producing blood components as an alternative source of blood transfusion. In the laboratory, other researchers use iPS cells derived from patients with blood disorders to better understanding how these diseases happen and how they could be prevented or better treated.

In the clinical area, researcher-physicians develop new methods of diagnosis and new treatment for leukemia, and also use new stem cells, like mesenchymal stem cells, for the treatment of many diseases, such as diabetes mellitus, systemic sclerosis and aplastic anemia.

A research duo finds that science and technology graduate students who turn away from academic careers do so because of changes in their own interests.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.